Ashly Jordan
Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York
MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis
Ashly Jordan is the Director of Research and Program Evaluation for the New York State Office of Addiction Services and Supports. She is an interdisciplinary epidemiologist with more than 15 years of applied research experience and public health practice focused on understanding how systems and interventions can improve health and social outcomes for people who use substances and who experience addiction. She has served as a consultant to the United Nations Office on Drugs and Crime. Dr. Jordan’s research has examined blood-borne and skin and soft tissue infections, tuberculosis, drug overdose, substance use epidemiology, and the impact of criminal legal involvement on substance use epidemiology and treatment trajectories. She has published extensively, including on prevention and care continua, Big Events theory, and novel metrics, and has served on study sections. Drawing on theory-based multi-level understanding of illness and health, and principles of health equity and social justice, Dr. Jordan’s research and public health practice has focused on the interplay between individual, social and structural factors on people who use substances.


Jordan AE, Bachhuber MA, Tuazon E, Jimenez C, Lincourt P, Hussain S, Rubinfeld J, Cunningham CO (2024).
Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations
Drug and Alcohol Dependence [Epub 2024 Apr 3]. doi: 10.1016/j.drugalcdep.2024.111283.

Nolen S, Trinidad AJ, Jordan AE, Green TC, Jalali A, Murphy SM, Zang X, Marshall BDL (2023).
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Harm Reduction Journal, 20 (1), 152. doi: 10.1186/s12954-023-00891-x. PMCID: PMC10585909.

Zaidi I, Jordan AE, Jessell L, Dominguez LG, Harocopos A, Nolan M (2023).
Housing status and COVID-19 prevention recommendations among people who use drugs
COVID, 3 (10), 1612-1621. doi: 10.3390/covid3100110.

Kapadia SN, Jordan AE, Eckhardt BJ, Perlman DC (2023).
The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination
Clinical Infectious Diseases [Epub 2023 Aug 27]. doi: 10.1093/cid/ciad503.

Jordan AE, Kashino W, Suhartono S, Campello G, Busse A (2023).
A systematic review and narrative synthesis of interventions to address substance use disorders and other mental health disorders in prison settings with a focus on low- and middle-income countries
Criminal Justice and Behavior, 50 (6), 787-805. doi: 10.1177/00938548231166155.


Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC (2015).
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.

Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.

Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.

Ashly Jordan's MyBibliography Profile